NYSE:A - Agilent Technologies Stock Price, Forecast & News

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, November 20th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.18 per share on Wednesday, January 22nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date of this dividend is Monday, December 30th. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.16. View Agilent Technologies' Dividend History.

Agilent Technologies declared that its board has initiated a share buyback plan on Monday, November 19th 2018, which authorizes the company to buyback $1,750,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 8.8% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's management believes its shares are undervalued.

Agilent Technologies Inc (NYSE:A) released its quarterly earnings results on Tuesday, February, 18th. The medical research company reported $0.81 earnings per share for the quarter, hitting the consensus estimate of $0.81. The medical research company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.36 billion. Agilent Technologies had a net margin of 14.59% and a return on equity of 20.49%. The company's revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, May 12th 2020. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share (EPS) guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.42. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.54 billion.

15 equities research analysts have issued 12-month price objectives for Agilent Technologies' shares. Their forecasts range from $57.00 to $100.00. On average, they expect Agilent Technologies' stock price to reach $84.50 in the next year. This suggests a possible upside of 8.4% from the stock's current price. View Analyst Price Targets for Agilent Technologies.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 7 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

Media headlines about A stock have trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Agilent Technologies earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Agilent Technologies.

Agilent Technologies saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 5,190,000 shares, an increase of 11.4% from the January 15th total of 4,660,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 3.2 days. Currently, 1.7% of the shares of the company are short sold. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Bruker (BRKR), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), AT&T (T), Alibaba Group (BABA), Netflix (NFLX), Walt Disney (DIS), Gilead Sciences (GILD), Boeing (BA), Paypal (PYPL) and Intel (INTC).

Agilent Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.36%), Artisan Partners Limited Partnership (1.84%), Geode Capital Management LLC (1.57%), Cantillon Capital Management LLC (1.33%), Pictet Asset Management Ltd. (1.11%) and Bank of New York Mellon Corp (0.86%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Geode Capital Management LLC, Schroder Investment Management Group, FMR LLC, Panagora Asset Management Inc., TD Asset Management Inc., AQR Capital Management LLC and Pendal Group Ltd. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was purchased by a variety of institutional investors in the last quarter, including Troy Asset Management Ltd, Marshall Wace LLP, Amundi Pioneer Asset Management Inc., Marshall Wace North America L.P., Pictet Asset Management Ltd., Hexavest Inc., Artisan Partners Limited Partnership and Jennison Associates LLC. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $77.95.

Agilent Technologies has a market capitalization of $24.18 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe.View Additional Information About Agilent Technologies.

The official website for Agilent Technologies is http://www.agilent.com/.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]